Brean Murray Carret & Co. Assumes Coverage on Onyx Pharmaceuticals (ONXX) at Hold
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $93.03 +0.13%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Trade ONXX Now!
Brean Murray Carret & Co. assumes coverage on Onyx Pharmaceuticals (NASDAQ: ONXX) with a Hold. PT $30.00.
Brean analyst says, "We view the majority of Onyx's value to be based on the indications for Nexavar of HCC and thyroid cancer, and carfilzomib. We project Nexavar to reach $2 billion in sales in 2015, or approximately $580 million in revenue to Onyx."
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $33.69 yesterday, with a 52 week range of $23.91-$45.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Brean analyst says, "We view the majority of Onyx's value to be based on the indications for Nexavar of HCC and thyroid cancer, and carfilzomib. We project Nexavar to reach $2 billion in sales in 2015, or approximately $580 million in revenue to Onyx."
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $33.69 yesterday, with a 52 week range of $23.91-$45.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Brean Capital Raises Onyx (ONXX) Price Target to $115
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- Deutsche Bank Starts Taylor Morrison Home (TMHC) at Hold, Says 'Risks Downplayed'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
